Search results
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 2 hours agoCRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So,...
Clearmind advances alcohol substitute beverage program By Investing.com
Investing.com· 49 minutes agoClearmind Medicine Inc. (NASDAQ:CMND), (FSE:CWY0), a biotech company specializing in the development...
Pleasing Signs As A Number Of Insiders Buy Aprea Therapeutics Stock
Simply Wall St. via Yahoo Finance· 3 hours agoUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders...
Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Target Price at $64.86
ETF DAILY NEWS· 12 hours agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the ...
Viridian Therapeutics (NASDAQ:VRDN) Earns Outperform Rating from Analysts at Wolfe Research
ETF DAILY NEWS· 7 hours agoInvestment analysts at Wolfe Research started coverage on shares of Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) in a note issued to investors on Tuesday, Briefing.com ...
Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Recommendation of “Hold” by Analysts
ETF DAILY NEWS· 13 hours agoFate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) has earned a consensus recommendation of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat ...
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time...
Motley Fool via Yahoo Finance· 6 hours agoShares of Structure Therapeutics (NASDAQ: GPCR) shot up more than 50% during the first week of June....
Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Anish Patel Sells 1,133 Shares
ETF DAILY NEWS· 9 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 1,133 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold ...
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals | The Motley Fool
The Motley Fool· 1 day agoViking Therapeutics (VKTX 0.70%) and Madrigal Pharmaceuticals (MDGL 4.31%) are highly prominent...
Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill...
Benzinga· 3 hours agoSkyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today announced the ...